Clinical Trials Directory

Trials / Completed

CompletedNCT01333436

A Study to Evaluate Fasting/Postprandial Serum Apolipoprotein B-48 (ApoB-48) Levels in Diabetic Participants With Normal to Moderately High Low Density Lipoprotein-C (LDL-C) Levels (MK-0653A-259 AM1)

A Multicenter, Cross-sectional Study to Evaluate Plasma ApoB-48 Concentration Among Korean Diabetic Patients (With Normal to Moderately High LDL-C Levels)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
93 (actual)
Sponsor
Organon and Co · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study will evaluate whether fasting/postprandial serum ApoB-48 levels are increased in diabetic participants compared to nondiabetic participants with the same range of serum LDL-C levels, and whether ApoB-48 levels can be used, along with LDL-C levels, to identify potential cardiovascular disease risk.

Conditions

Interventions

TypeNameDescription
OTHERTest MealDuring Visit 2, a test meal will be supplied by the Sponsor of approximately 944 kcal (57% fat, 31% carbohydrate, and 12% protein), and postprandial blood draws will be done at 1, 2, 3, 4, and 6 hours after the meal.

Timeline

Start date
2011-07-20
Primary completion
2012-05-12
Completion
2012-05-12
First posted
2011-04-12
Last updated
2024-05-13
Results posted
2013-04-09

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01333436. Inclusion in this directory is not an endorsement.